ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Non-Small-Cell Lung Carcinoma

Endometrial Cancer trials near Cincinnati, OH, USA:

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...

Enrolling
Endometroid Endometrial Cancer
Drug: Fulvestrant injection
Drug: Alpelisib Pill

Phase 2

GOG Foundation

Kettering, Ohio, United States and 10 other locations

Locations recently updated

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Cincinnati, Ohio, United States and 220 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Dayton, Ohio, United States and 202 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Cincinnati, Ohio, United States and 162 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Diagnostic Test: OncoSignature
Drug: ACR-368

Phase 1, Phase 2

Acrivon Therapeutics

Cincinnati, Ohio, United States and 66 other locations

will also assess the clinical benefit of combination therapy in participants with advanced unresectable and/or metastatic ICI refractory solid tumors...

Enrolling
Esophageal Cancer
Colo-rectal Cancer
Drug: NC410
Drug: pembrolizumab

Phase 1, Phase 2

NextCure

Cincinnati, Ohio, United States and 16 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Cisplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 93 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

Kettering, Ohio, United States and 123 other locations

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....

Enrolling
Endometrial Cancer
Advanced Solid Tumor
Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Cincinnati, Ohio, United States and 59 other locations

A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patie...

Active, not recruiting
Solid Tumor
Breast Cancer
Drug: AMXT1501
Drug: DFMO

Phase 1, Phase 2

Aminex Therapeutics

Cincinnati, Ohio, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems